Allergy Relief
Product Images NDC 59726-564

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Allergy Relief (NDC 59726-564). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by P & L Development, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fexofenadine HCl Usp 180 mg (Fexofenadine HCl 180 mg Tablets Mia 1)

Fexofenadine HCl Usp 180 mg (Fexofenadine HCl 180 mg Tablets Mia 1)
This is a drug container with 180 mg fexofenadine tablets, which are antihistamines intended to alleviate allergies that happen indoors or outdoors. It is advised to consult a doctor before use in case of any eye disease, kidney disease, or allergies to the product. The inactive substances should be taken according to the prescription, and it should not be used in conjunction with various antacids or fruit juices. If someone has an allergic reaction to the product, they should discontinue use immediately and seek immediate medical attention if an overdose occurs. Pregnant and nursing women should seek a healthcare provider's advice. The packaging has complete warnings and product information, and the outer carton should be retained. There is a tamper-evident seal attached to the container.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.